LIRYC

inHEART appoints industry veteran Todor Jeliaskov as new CEO to drive commercial growth

Retrieved on: 
Thursday, October 21, 2021
Arrhythmia, BioSense, Technology, Cardiology, Norwest Venture Partners, MBA, Organization, Patient, VC, Leadership, Doctor of Philosophy, VP, CEO, Growth, Cardiac electrophysiology, Siemens Healthineers, ICE, Health, Electrical engineering, CTO, LIRYC, DNA, Management, Medical imaging, Medical device

PESSAC, France, Oct. 21, 2021 /PRNewswire/ -- inHEART , the leader in image guidance for treatment of cardiac arrhythmias, has appointed Todor Jeliaskov as CEO.

Key Points: 
  • PESSAC, France, Oct. 21, 2021 /PRNewswire/ -- inHEART , the leader in image guidance for treatment of cardiac arrhythmias, has appointed Todor Jeliaskov as CEO.
  • Todor Jeliaskov will work closely with co-founder and former CEO Jean-Marc Peyrat, who transitions to the role of CTO at inHEART.
  • "I am thrilled to welcome Todor as our new CEO," said Jean-Marc Peyrat, co-founder of inHEART.
  • Before inHEART, Todor Jeliaskov was CEO of NuVera Medical, acquired by Biosense Webster (Johnson & Johnson) in November 2020.

inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations

Retrieved on: 
Thursday, July 2, 2020
RTT, Circulatory system, Branches of biology, Medicine, Cardiac electrophysiology, Catheter ablation, Heart arrhythmia, Heart, Catheter, LIRYC, Clinical cardiac electrophysiology, Cardiology

Heart rhythm disorders, notably as the cause of sudden cardiac death, is a major cause of morbidity in the world.

Key Points: 
  • Heart rhythm disorders, notably as the cause of sudden cardiac death, is a major cause of morbidity in the world.
  • Current treatment solutions for patients with arrhythmias are not optimal whether considering drugs, implantable devices or even catheter ablation procedures that are lengthy, complex and expensive.
  • inHEART provides a cloud-based software solution that transforms preoperative medical images into a 3D digital twin of the patient's heart.
  • inHEART is a spin-off from IHU Liryc and Inria, two worldwide leading centers respectively in cardiac electrophysiology and digital science and technology.